Skip to main content.

A Bad Day for Meridia and "Pink Viagra"

A Bad Day for Meridia and "Pink Viagra"

Picture of Barbara Feder Ostrov

Here's what we're reading today:

Health Reform: It's official: a federal judge finally rules that the new health reform law is constitutional. The ruling was hailed as a victory for the Obama administration because it's the first to dismiss a constitutional challenge on its merits rather than a technicality. The Washington Post's N.C. Aizenman has the story.

Little Pink Pill: The quest for a female version of Viagra suffers a setback as the FDA finds little evidence that the chemical flibanserin, originally discovered as a depressant, actually works to increase sexual desire.

Meridia: In other pharma news, the maker of weight-loss drug Meridia pulls it off the market over heart health concerns.

Crowdsourcing: Should doctors use crowdsourcing to treat their patients? Darshak Sanghavi examines the debate for Slate. Also check out Sanghavi's tips on covering health care quality at ReportingonHealth.

Health 2.0: If you can't get to the Health 2.0 conference in San Francisco today, check out this recap and follow the Twitter conversation at hashtag #health2con. What is Health 2.0? Check out this definition.

Leave A Comment

Announcements

Our California Impact Fund offers mentorship and support to reporters who think big and want to make a difference in their communities through investigative or explanatory reporting on promising approaches to chronic ills. 

The nation's top infectious disease specialist will join us for a conversation with national health reporter Dan Diamond of The Washington Post. We’ll talk about the evolving threat posed by monkeypox, the current state of the COVID pandemic, and broader lessons on how we respond to emerging diseases. Sign-up here!

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth